Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
STT3B-CDG is a form of congenital disorders of N-linked glycosylation characterized by intrauterine growth retardation, microcephaly, failure to thrive, developmental delay, intellectual disability, hypotonia, seizures, optic nerve atrophy and respiratory difficulties. Genital abnormalities (micropenis, hypoplastic scrotum, undescended testes) have also been reported. STT3B-CDG is caused by mutations in the gene STT3B (3p24.1).
Features include always present findings: Microcephaly, Shrinkage of the cerebellum (cerebellar atrophy), Feeding difficulties, and Seizure and others; and common findings: Micropenis, Small scrotum, Respiratory distress, and Damage to the optic nerve (optic atrophy) and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 4 | Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Damage to the optic nerve (optic atrophy) |
STT3B function has not been fully characterized.
STT3B-congenital disorder of glycosylation is associated with mutations in the STT3B gene on chromosome 3.
Genetic testing for STT3B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for STT3B-congenital disorder of glycosylation has been reported in the published literature.
Phenotype severity distribution: 10 always present features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for STT3B-congenital disorder of glycosylation.
206 publications have been identified in PubMed for STT3B-congenital disorder of glycosylation. Kisho has analyzed 134 by research type. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (38%), and Diagnostic / Biomarker (4%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 67 | 50% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 10:20 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about STT3B-congenital disorder of glycosylation
Brain and nerves | 3 | Seizure, Global developmental delay, Intellectual disability |
Growth and development | 2 | Failure to thrive, Intrauterine growth retardation |
Head and neck | 1 | Microcephaly |
Digestive system | 1 | Feeding difficulties |
Lungs and breathing | 1 | Respiratory distress |
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
Blood and immune system | 1 | Low platelet count (thrombocytopenia) |
Laboratory research |
51 |
38% |
Testing and diagnosis research | 5 | 4% |
Patient case studies | 4 | 3% |
Disease patterns and progression | 4 | 3% |
New treatment approaches | 2 | 1% |
Other research | 1 | 1% |
Driesen K (2026). [PMID: 41570364](https://pubmed.ncbi.nlm.nih.gov/41570364/). *Mol Genet Metab*. [Basic Science / Preclinical]
Yi L (2026). [PMID: 41264770](https://pubmed.ncbi.nlm.nih.gov/41264770/). *Protein Cell*. [Review / Meta-Analysis]
Tawfik CA (2026). [PMID: 41667393](https://pubmed.ncbi.nlm.nih.gov/41667393/). *Ophthalmic Genet*. [Case Report / Case Series]
Ding S (2026). [PMID: 41939861](https://pubmed.ncbi.nlm.nih.gov/41939861/). *Front Immunol*. [Review / Meta-Analysis]
Tachida Y (2026). [PMID: 41917388](https://pubmed.ncbi.nlm.nih.gov/41917388/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Ünsal Y (2026). [PMID: 39975416](https://pubmed.ncbi.nlm.nih.gov/39975416/). *J Clin Res Pediatr Endocrinol*. [Review / Meta-Analysis]
Gunderman L (2026). [PMID: 41777878](https://pubmed.ncbi.nlm.nih.gov/41777878/). *Frontiers in immunology*. [Case Report / Case Series]
Johannes L (2026). [PMID: 41173705](https://pubmed.ncbi.nlm.nih.gov/41173705/). *Trends Cell Biol*. [Review / Meta-Analysis]
Gleeson PA (2026). [PMID: 41713215](https://pubmed.ncbi.nlm.nih.gov/41713215/). *Biochim Biophys Acta Gen Subj*. [Review / Meta-Analysis]
Fu B (2026). [PMID: 41559085](https://pubmed.ncbi.nlm.nih.gov/41559085/). *Nat Commun*. [Diagnostic / Biomarker]